Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma
β Scribed by Takahiro Uenishi; Shuhei Nishiguchi; Shogo Tanaka; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 77 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Patients with high viral load (β₯1.0βΓβ10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the
## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first